PCSK9 Inhibition with alirocumab increases the catabolism...

PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)

Watts, Gerald F., Chan, Dick C., Pang, Jing, Ma, Louis, Ying, Qidi, Aggarwal, Shashi, Marcovina, Santica M., Barrett, P. Hugh R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
107
Journal:
Metabolism
DOI:
10.1016/j.metabol.2020.154221
Date:
June, 2020
File:
PDF, 715 KB
2020
Conversion to is in progress
Conversion to is failed